Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

References

• EganBMZhaoYAxonRNUS trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008JAMA2010303202043205020501926
   PubMed Web of Science ®Google Scholar
• RosendorffCBlackHRCannonCPAmerican Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and PreventionTreatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and PreventionCirculation2007115212761278817502569
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating CommitteeThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA2003289192560257212748199
   PubMed Web of Science ®Google Scholar
• BlackHRElliottWJGranditsGCONVINCE Research GroupPrincipal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trialJAMA2003289162073208212709465
   PubMed Web of Science ®Google Scholar
• MoriHUkaiHYamamotoHCurrent status of antihypertensive prescription and associated blood pressure control in JapanHypertens Res200629314315116755149
   PubMed Web of Science ®Google Scholar
• QvarnstromMWettermarkBLjungmanCAntihypertensive treatment and control in a large primary care population of 21 167 patientsJ Hum Hypertens201125848449120720572
   PubMed Web of Science ®Google Scholar
• KjeldsenSEOsIHoieggenABeckeyKGleimGWOparilSFixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazideAm J Cardiovasc Drugs200551172215631534
   PubMedGoogle Scholar
• Mylan PharmaceuticalsHydrochlorothiazide capsule Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=10039Accessed February 24, 2011
   Google Scholar
• DuarteJDCooper-DeHoffRMMechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diureticsExpert Rev Cardiovasc Ther20108679380220528637
   PubMedGoogle Scholar
• OparilSWilliamsDChrysantSGMarburyTCNeutelJComparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertensionJ Clin Hypertens (Greenwich)20013528329131811588406
   PubMedGoogle Scholar
• WeirMRPunziHAFlackJMA randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertensionPostgrad Med20111231808721293087
   PubMed Web of Science ®Google Scholar
• GilesTDOparilSSilfaniTNWangAWalkerJFComparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertensionJ Clin Hypertens (Greenwich)20079318719517341994
   PubMedGoogle Scholar
• GilesTDOparilSWangADubielRAn evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertensionJ Am Soc Hypertens20093639540220409982
   PubMed Web of Science ®Google Scholar
• WhiteWBWeberMASicaDEffects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertensionHypertension201157341342021282560
   PubMed Web of Science ®Google Scholar
• LeMTPugsleyMKVauquelinGVan LiefdeIMolecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptorBr J Pharmacol2007151795296217572702
   PubMed Web of Science ®Google Scholar
• ZannadFFayRBlood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studiesFundam Clin Pharmacol200721218119017391291
   PubMed Web of Science ®Google Scholar
• BENICAR (olmesartan medoxomil)US prescribing informationParsippany, NJDaiichi Sankyo, Inc2010
   Google Scholar
• KreutzRBolbrinkerJHuberMPharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjectsClin Drug Invest20062612934
   Web of Science ®Google Scholar
• MizunoMSadaTIkedaMPharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonistEur J Pharmacol199528521811888566137
   PubMed Web of Science ®Google Scholar
• ChrysantSGWeberMAWangACHinmanDJEvaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazideAm J Hypertens200417325225915001200
   PubMed Web of Science ®Google Scholar
• KereiakesDJNeutelJMPunziHAXuJLipkaLJDubielREfficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylateAm J Cardiovasc Drugs20077536137217953475
   PubMed Web of Science ®Google Scholar
• OparilSChrysantSGKereiakesDResults of an olmesartan medoxomil-based treatment regimen in hypertensive patientsJ Clin Hypertens (Greenwich)2008101291192119120717
   PubMed Web of Science ®Google Scholar
• OparilSPimentaEEfficacy of an olmesartan medoxomil-based treatment algorithm in patients stratified by age, race, or sexJ Clin Hypertens (Greenwich)201012131320047622
   PubMed Web of Science ®Google Scholar
• RumpLCGirerdXSellinLStegbauerJEffects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertensionJ Hum Hypertens201125956557421107435
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionNational Diabetes Statistics2011 Available at: http://diabetes.niddk.nih.gov/DM/PUBS/statistics/DM_Statistics.pdfAccessed February 22, 2011
   Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2011Diabetes Care201134Suppl 1S11S6121193625
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial HypertensionJ Hypertens20072591751176217762635
   PubMed Web of Science ®Google Scholar
• CushmanWCEvansGWByingtonRPEffects of intensive blood-pressure control in type 2 diabetes mellitusN Engl J Med2010362171575158520228401
   PubMed Web of Science ®Google Scholar
• ChobanianAVClinical practice. Isolated systolic hypertension in the elderlyN Engl J Med2007357878979617715411
   PubMed Web of Science ®Google Scholar
• RogerVLGoASLloyd-JonesDMHeart disease and stroke statistics – 2011 update: a report from the American Heart AssociationCirculation20111234e18e20921160056
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)JAMA199126524325532642046107
   PubMed Web of Science ®Google Scholar
• KarioKPickeringTGUmedaYMorning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective studyCirculation2003107101401140612642361
   PubMed Web of Science ®Google Scholar
• GossePLasserreRMinifieCLemetayerPClementyJBlood pressure surge on risingJ Hypertens20042261113111815167445
   PubMed Web of Science ®Google Scholar
• HermidaRCAyalaDEFernandezJRPortaluppiFFabbianFSmolenskyMHCircadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medicationsAm J Hypertens201124438339120930708
   PubMed Web of Science ®Google Scholar
• ChavanuKMerkelJQuanAMRole of ambulatory blood pressure monitoring in the management of hypertensionAm J Health Syst Pharm200865320921818216005
   PubMed Web of Science ®Google Scholar
• PickeringTGWhiteWBASH Position Paper: Home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoringJ Clin Hypertens (Greenwich)2008101185085519128274
   PubMed Web of Science ®Google Scholar
• PunziHAWhy ambulatory blood pressure monitoring?Am J Health Syst Pharm199855Suppl 3S12169825044
   PubMed Web of Science ®Google Scholar
• KereiakesDJNeutelJStoakesKAThe effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and olderJ Clin Hypertens (Greenwich)200911841142119695028
   PubMed Web of Science ®Google Scholar
• NeutelJMKereiakesDJWaverczakWFStoakesKAXuJShojaeeAEffects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetesCurr Med Res Opin201026372172820085534
   PubMed Web of Science ®Google Scholar
• KereiakesDNeutelJSeated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitusDrugs R D20111131721410293
   PubMedGoogle Scholar
• NeutelJKereiakesDJStoakesKAMaaJShojaeeAWaverczakWFBlood pressure-lowering efficacy of an olmesartan medoxomil/ hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥ 65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration studyDrugs Aging201128647749021639407
   PubMed Web of Science ®Google Scholar
• PickeringTGHallJEAppelLJRecommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure ResearchCirculation2005111569771615699287
   PubMed Web of Science ®Google Scholar
• Daiichi Sankyo Inc.Benicar HCT (olmesartan medoxomil and hydrochlorothiazide) tablet, film coated2007 Available at: http://www.benicar.com/pdf/prescribing_information_HCT.pdfAccessed March 17, 2011
   Google Scholar
• Benicar HCT® (olmesartan medoxomil and hydrochlorothiazide)US prescribing informationParsippany, NJDaiichi Sankyo, Inc2007
   Google Scholar
• IzzoJLJrNeutelJMSilfaniTDubielRWalkerFEfficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/ HCTZ: results of an open-label titration studyJ Clin Hypertens (Greenwich)200791364417215657
   PubMedGoogle Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet20023599311995100311937178
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialLancet200436394262022203115207952
   PubMed Web of Science ®Google Scholar
• HallerHItoSIzzoJLJrOlmesartan for the delay or prevention of microalbuminuria in type 2 diabetesN Engl J Med20113641090791721388309
   PubMed Web of Science ®Google Scholar
• GrassiGThe ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesExpert Opin Pharmacother201112152421242421767225
   PubMed Web of Science ®Google Scholar
• VA Cooperative Study GroupEffects of treatment on morbidity in hypertensionJAMA1967202102810344862069
   PubMed Web of Science ®Google Scholar
• VA Cooperative Study GroupEffects of treatment on morbidity in hypertensionJAMA1970213114311524914579
   PubMed Web of Science ®Google Scholar
• CarterBLErnstMECohenJDHydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeabilityHypertension20044314914638621
   PubMed Web of Science ®Google Scholar
• NeffKMNawarskasJJHydrochlorothiazide versus chlorthalidone in the management of hypertensionCardiol Rev2010181515620010338
   PubMed Web of Science ®Google Scholar
• Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research GroupJAMA198224812146514777050440
   PubMed Web of Science ®Google Scholar
• SiegelDHulleySBBlackDMDiuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive menJAMA19922678108310891735925
   PubMed Web of Science ®Google Scholar
• FickDMCooperJWWadeWEWallerJLMacleanJRBeersMHUpdating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of expertsArch Intern Med2003163222716272414662625
   PubMed Web of Science ®Google Scholar
• NeutelJMKereiakesDJAn olmesartan medoxomil-based treatment algorithm is effective in achieving 24-hour BP control in patients with type 2 diabetes mellitus, regardless of age, race, sex, or severity of hypertension: subgroup analysis of the BENIFICIARY studyAm J Cardiovasc Drugs201010528930320712386
   PubMed Web of Science ®Google Scholar
• PunziHAPunziCFMetabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial StudyCurr Hypertens Rep20046210611015010012
   PubMed Web of Science ®Google Scholar
• JamersonKADevereuxRBakrisGLEfficacy and duration of benazepril plus amlodipine or hydrochlorthiazide on 24-hour ambulatory systolic blood pressure controlHypertension201157217417921189401
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med2008359232417242819052124
   PubMed Web of Science ®Google Scholar
• Major PharmaceuticalsAmlodipine besylate tablet2009 Available at: http://nccs-dailymed-1.nlm.nih.gov/dailymed/drugInfo.cfm?id=11136#nlm42230-3Accessed March 17, 2011
   Google Scholar
• Tribenzor® (olmesartan medoxomil, amlodipine, hydrochlorothiazide)US prescribing informationParsippany, NJDaiichi Sankyo, Inc2011
   Google Scholar